Skin TLR7 triggering promotes accumulation of respiratory dendritic cells and natural killer cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Hackstein, Holger ^a   Hagel, Nicole ^a   Knoche, Angela ^a   Kranz, Sabine ^a   Lohmeyer, Jürgen ^b   von Wulffen, Werner ^c   Kershaw, Olivia ^d   Gruber, Achim D ^d   Bein, Gregor ^a   Baal, Nelli ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Department of Internal Medicine II ^*  (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; IMIQUIMOD; INTERLEUKIN 10; INTERLEUKIN 12P70; PLACEBO; PROGRAMMED DEATH 1 LIGAND 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGGREGATION; CELL STIMULATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; EXPERIMENTAL STUDY; FLOW CYTOMETRY; HELPER CELL; HISTOPATHOLOGY; IMMUNOMODULATION; KLEBSIELLA PNEUMONIAE; LEUKOCYTE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; RESPIRATORY SYSTEM;

AMINOQUINOLINES; ANIMALS; ANTIGENS, CD274; ANTIGENS, CD86; B-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; KILLER CELLS, NATURAL; LIGANDS; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; SKIN; TOLL-LIKE RECEPTOR 7;

EID: 84865180272     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043320     Document Type: Article

References (29)

1. Miller RL, Meng TC, Tomai MA, (2008) The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect 21 (2): 69-87.
2. Smits EL, Ponsaerts P, Berneman ZN, van Tendeloo VF, (2008) The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist 13 (8): 859-875.
3. Wagstaff AJ, Perry CM, (2007) Topical imiquimod. a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Drugs 67 (15): 2187-2210.
4. Gaspari A, Tyring S, Rosen T, (2009) Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol 8 (5): 467-474.
5. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168 (9): 4531-4537.
6. Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, et al. (2002) Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 195 (11): 1507-1512.
7. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C, (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (5663): 1529-1531.
8. Larange A, Antonios D, Pallardy M, Kerdine-Romer S, (2009) TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation. J Leukoc Biol 85 (4): 673-683.
9. Berghofer B, Frommer T, Haley G, Fink L, Bein G, et al. (2006) TLR7 ligands induce higher IFN-alpha production in females. J Immunol 177 (4): 2088-2096.
10. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, et al. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303 (5663): 1526-9. Epub 2004 Feb 19.
11. Moisan J, Camateros P, Thuraisingam T, Marion D, Koohsari H, et al. (2006) TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am J Physiol Lung Cell Mol Physiol 290 (5): L987-95.
12. Aumeunier A, Grela F, Ramadan A, Pham Van L, Bardel E, et al. (2010) Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 5 (7): e11484.
13. Xirakia C, Koltsida O, Stavropoulos A, Thanassopoulou A, Aidinis V, et al. (2010) Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am J Respir Crit Care Med 181 (11): 1207-1216.
14. Berghofer B, Haley G, Frommer T, Bein G, Hackstein H, (2007) Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production. J Immunol 178 (7): 4072-4079.
15. Stein P, Weber M, Prufer S, Schmid B, Schmitt E, et al. (2011) Regulatory T cells and IL-10 independently counterregulate cytotoxic T lymphocyte responses induced by transcutaneous immunization. PLoS One 6 (11): e27911.
16. Gunzer M, Riemann H, Basoglu Y, Hillmer A, Weishaupt C, et al. (2005) Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion. Blood 106 (7): 2424-2432.
17. Baenziger S, Heikenwalder M, Johansen P, Schlaepfer E, Hofer U, et al. (2009) Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 113 (2): 377-388.
18. Pockros PJ, Guyader D, Patton H, Tong MJ, Wright T, et al. (2007) Oral resiquimod in chronic HCV infection. safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. J Hepatol 47 (2): 174-182.
19. Pasmatzi E, Chaidaroglou A, Sakkis T, Monastirli A, Georgiou S, et al. (2009) Topical application of imiquimod induces alterations in peripheral blood lymphocytes in healthy individuals. Acta Derm Venereol 89 (2): 134-139.
20. Xiong Z, Ohlfest JR, (2011) Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumors. J Immunother 34 (3): 264-269.
21. Banchereau J, Steinman RM, (1998) Dendritic cells and the control of immunity. Nature 392 (6673): 245-252.
22. Hackstein H, Thomson A, (2004) Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4 (1): 24-34.
23. Lu H, Wagner W, Gad E, Yang Y, Duan H, et al. (2010) Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade. J Immunol 184 (9): 5360-5367.
24. Kim T, Braciale T, (2009) Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One 4 (1): e4204.
25. Maus U, Herold S, Muth H, Maus R, Ermert L, et al. (2001) Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am J Physiol Lung Cell Mol Physiol 280 (1): L58-68.
26. Hackstein H, Wachtendorf A, Baal N, Kranz S, Lohmeyer J,et al. Heterogeneity of dendritic cell subsets and lymphocyte populations in inbred mouse strains. (submitted) Respir Res.
27. Lohr J, Knoechel B, Jing J, Villarino AJ, Abbas A, (2006) Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J exp Med 203: 2785-2791.
28. Henri S, Poulin LF, Tamoutounnour S, Ardouin L, Guilliams M, et al. (2010) CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 207: 189-206.
29. Kane KL, Ashton FA, Schmitz JL, Folds JD, (1996) Determination of natural killer cell function by flow cytometry. Clin Diagn Lab Immunol 3: 295-300.